Instead, a lower dose (5 mg rosuvastatin) was used in view of the known history of CPT2 deficiency and the propensity of any underlying myopathy to be aggravated by statin therapy [8, 9]. Here, CPT2 is linked to hyperinsulinemic hypoglycemia, familial, 4.